Figure 4.
Plasma concentration–time curves for (−)-agelastatin A [(−)-1a] after a single 2.5 mg/kg dose using both IV and IP administration routes. Concentrations of (−)-1a were determined by LCMS.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.